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Abstract
Francisella tularensis subspecies tularensis (type A) and holarctica (type B) are of clinical importance in causing tularemia.
Molecular typing methods have further separated type A strains into three genetically distinct clades, A1a, A1b and A2.
Epidemiological analyses of human infections in the United States suggest that A1b infections are associated with a
significantly higher mortality rate as compared to infections caused by A1a, A2 and type B. To determine if genetic
differences as defined by molecular typing directly correlate with differences in virulence, A1a, A1b, A2 and type B strains
were compared in C57BL/6 mice. Here we demonstrate significant differences between survival curves for infections caused
by A1b versus A1a, A2 and type B, with A1b infected mice dying earlier than mice infected with A1a, A2 or type B; these
results were conserved among multiple strains. Differences were also detected among type A clades as well as between
type A clades and type B with respect to bacterial burdens, and gross anatomy in infected mice. Our results indicate that
clades defined within F. tularensis subsp. tularensis by molecular typing methods correlate with virulence differences, with
A1b strains more virulent than A1a, A2 and type B strains. These findings indicate type A strains are not equivalent with
respect to virulence and have important implications for public health as well as basic research programs.
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Introduction
Francisella tularensis is the etiologic agent of the zoonotic disease
tularemia and one of the most infectious bacterial pathogens
known to humans and animals. The infectious dose of this
bacterium is between 10 and 50 CFU in humans depending upon
the route of infection [1]. Tularemia can be acquired through the
bite of an infected arthropod (ticks, deerflies and mosquitoes), by
handling infected animal carcasses, through the ingestion of
contaminated food or water, and by inhalation of infective
aerosols. Distinct clinical presentations of tularemia occur and are
dependent upon the route of infection [1,2].
Two subspecies of F. tularensis, subspecies tularensis (type A) and
subspecies holarctica (type B) are of clinical importance in causing
tularemia [3]. Differentiation between these two subspecies is
based on biochemical testing, molecular typing methods, viru-
lence, and epidemiological characteristics [3,4-11]. Geographical-
ly, F. tularensis subsp. tularensis infections are documented only in
North America, as compared to F. tularensis subsp. holarctica
infections which occur in Europe, Asia and North America [1,4,5].
Virulence differences between F. tularensis subsp. tularensis and
subsp. holarctica have been demonstrated in rabbits, with one
bacterial cell of an F. tularensis subsp. tularensis strain sufficient to
cause 100% mortality as compared to 10
9 cells required for an F.
tularensis subsp. holarctica strain [4].
Pulsed-field gel electrophoresis (PFGE) and whole genome
single nucleotide polymorphism (SNP) typing of F. tularensis subsp.
tularensis strains have subdivided this subspecies into three
genetically distinct clades, A1a, A1b and A2 [8,12,13]. Histori-
cally, F. tularensis subsp. tularensis strains have been considered to be
of similar virulence. However, recent epidemiological analysis of
culture-confirmed human infections in the United States showed
that infections caused by A1b strains resulted in significantly
higher mortality (24%) than infections caused by A1a (4%), A2
(0%) or type B (7%) strains [12]. Logistic regression analysis of A1b
infections indicated that this higher mortality rate was not linked
to host characteristics, including age or immune status, suggesting
that A1b strains have an intrinsic characteristic which makes them
more virulent than A1a, A2 or type B strains.
The objective of the present study was to determine if genetic
differences, as defined by molecular typing, directly correlate
with differences in virulence in infected mice. Mice are not
commonly used to compare virulence of F. tularensis strains, as
early reports indicated no difference in LD50 between type A and
type B strains [1,14,15]. However, Olsufiev et al. demonstrated
differences in time to death between mice infected with a type A
strain (Schu) and a type B strain (503) [4]. More recently, when
type A and type B strains were compared using aerosol,
intradermal, and intravenous routes of infection in both
BALB/c and C57BL/6 mice, type A infected mice succumbed
to infection approximately one day earlier than mice infected
with type B [16]. A separate study reported significant differences
in survival curves between two type A strains (FSC033 and Schu
S4) in BALB/c mice [17].
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and gross anatomy for mice infected with the three type A clades,
A1a, A1b and A2, as well as type B. Significant differences in
survival curves (scale and shape) were observed between F.
tularensis subsp. tularensis clades, as well as between these clades and
type B, with A1b infected mice dying sooner than A1a, A2 or type
B infected mice.
Materials and Methods
Bacterial isolates and preparation of inoculum
All F. tularensis strains (n=8) used to infect mice originated from
human cases of tularemia (Table 1). Strains were grown from
frozen stocks (270uC) on cysteine heart agar with 9% chocolatized
sheep blood (CHAB) at 35uC for 48 h, followed by subculture onto
CHAB for 24 h at 35uC. Bacterial suspensions for inoculations
were prepared in sterile saline. Colony forming units in each
inoculum were verified by spotting 50 ml of the inoculum onto
each quadrant of two CHAB quad plates (8 replicates total) and
letting the plates dry without spreading. Colony forming units
were counted after 48–72 hours of growth at 35uC.
Pulsed-field gel electrophoresis
All F. tularensis strains were characterized using PmeI pulsed-field
gel electrophoresis [8,12]. PFGE patterns were analyzed by
BioNumerics, version 5.0 (Applied Maths, BVBA, Sint-Martens-
Latem, Belgium), with gels normalized using AscI restricted
Salmonella enterica serotype Braenderup strain H9812. A dendogram
was generated using Dice similarity coefficients and unweighted
pair group method with averages (1.5% tolerance, 1.5%
optimization).
Animal infections
Specific-pathogen free female C57BL/6J mice, (The Jackson
Laboratory, Bar Harbor, ME) 8–9 weeks of age, were used. For F.
tularensis infections, mice were anesthetized by inhalation of
isoflurane to effect and infected intradermally with 50 ml via the
tail dermis. Control mice were inoculated with 50 ml of saline.
Seven mice were infected with each strain to ensure sufficient
power to detect a scale shift in the fitted survival curve of at least
one day. Experiments were performed in two rounds, with each
round consisting of mice being infected with one strain for each F.
tularensis group (A1a, A1b, A2 and type B). Infected mice were
monitored every 1–2 hours (minimum of 12 observations per day)
until death. Mice were weighed prior to infection and at time of
death. Mice were given food ad libitum and an exercise wheel was
provided in every cage. All animal procedures were approved by
the Division of Vector-Borne Infectious Diseases Institutional
Animal Care and Use Committee (protocol number 08–012) and
performed in accordance with the guidelines on the care and use
of laboratory animals [18]. The temperature of infected mice was
also monitored in these experiments in order to identify an ethical,
unbiased surrogate endpoint for death (manuscript in prepara-
tion). All animal experiments with F. tularensis were conducted in
ABL3 facilities.
Quantitative bacteriology
Necropsies were performed at the time of death. Whole organs
(lungs, spleen, and liver) were removed aseptically from infected
and control mice. Liver and lungs were briefly submerged into
sterile saline to remove any traces of contaminating blood, and
excess saline was dabbed onto a sterile petri dish. Each organ was
weighed and then sterile saline added (5 ml for spleen and lungs
and 10 ml for liver) prior to homogenization using a Stomacher 80
micro Biomaster (Seward, Bohemia, NY). Homogenized samples
were 10 fold serially diluted in sterile saline up to 10
8 and serial
dilutions (dependent on sample) spotted (50 ml) in duplicates onto
CHAB quad plates, with plates allowed to dry without spreading.
Colonies were counted after 48–72 hours of growth at 35uC.
Whole blood was collected from the abdominal aorta and 10 fold
serially diluted into sterile saline to a 10
8 dilution and serial
dilutions, 10
6,1 0
7 and 10
8, plated as described above.
Data and statistical analyses
Empirical survival curves were generated by plotting proportion
of surviving mice against time of death (hours). Median time to
death was determined using JMP 7 version 7.0.2 software (SAS,
Cary, NC). Survival curves were modeled according to a Weibull
distribution using S-Plus 8.0 software (TIBCO Software Inc, Palo
Alto, CA) allowing different shape and scale parameter estimates
for the four groups and two rounds of experiments. Residual plots
and goodness of fit tests were used to validate the model fit. To
determine if survival curves differed in round 1 and round 2, fitted
survival curves for the two strains within each of the 4 groups (A1a,
A1b, A2 and type B) were compared across the two rounds of
experiments following Lee [19]. A Bonferroni adjustment was
made to account for multiple comparisons, with the overall
probability of a Type I error being 0.05. Additionally, a survival
regression model was fit with terms for interaction between group
and round.
For bacterial burden, mouse weight and organ weight
comparisons, a weighted 2-way MANOVA was used followed
Table 1. Francisella tularensis strains used in this study.
CDC Accession
Number
Francisella tularensis
Subspecies Clade Year Isolated Geographic Origin Round Used Average Inoculum (CFU)
OK01-2528 tularensis A1a 2001 Oklahoma 1 1663
MO02-4195 tularensis A1a 2002 Missouri 2 1164
MD00-2970 tularensis A1b 2000 Maryland 1 1362
MA00-2987 tularensis A1b 2000 Massachusetts 2 1064
WY96-3418 tularensis A2 1996 Wyoming 1 1464
NM99-1823 tularensis A2 1999 New Mexico 2 1163
KY99-3387 holarctica - 1999 Kentucky 1 1463
MI00-1730 holarctica - 2000 Michigan 2 1466
doi:10.1371/journal.pone.0010205.t001
F. tularensis Clade Virulence
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multiple comparisons with the overall probability of a Type I error
being 0.05. The main effects in the MANOVA were group and
round, and an interaction term between the two was also included
to determine if the group effect was consistent between rounds.
Results
Genotype comparison of F. tularensis strains
F. tularensis strains originated from culture-confirmed cases of
human tularemia in the United States and were classified into one
of four groups, A1a, A1b, A2, or type B, by PFGE typing (Table 1;
Figure 1). A total of eight F. tularensis strains, two representative
strains for each of the four groups, were included (Table 1). Each
set of two strains was chosen based on differences in geographical
origin and year isolated. Where possible, strains with differing
PFGE patterns were chosen to ensure strain diversity within each
of the 4 groups (Figure 1).
Survival comparison of mice infected with F. tularensis
A1a, A1b, A2 and type B strains
For each F. tularensis strain (n=8), seven naı ¨ve C57BL/6J mice
were infected intradermally. At the time of infections, colony
counts within each inoculum were determined in octuplicate, with
the average colony forming units per inoculum ranging from 10
to16 (Table 1). The time of death for A1a, A1b, A2, and type B
infected mice ranged from 117 h to168 h, 82 h to169 h, 92 h to
212 h, and 113 h to 242 h, respectively (Figure 2a). Median times
to death were 146 h, 132.5 h, 155 h, and 206.5 h for A1a, A1b,
A2 and type B infected mice, respectively (Figure 2b). The median
time to death for mice infected with A1b strains was 14, 22, and
74 hrs earlier than mice infected with A1a, A2 or type B strains,
respectively.
A regression was performed on all 8 strains with survival time as
the response and assuming a Weibull distribution for survival
times. In the regression, both the scale and shape parameters of
the Weibull distribution were expressed as linear functions of F.
tularensis group and experimental round (e.g. round 1 or round 2).
The interaction term between group and round was not
statistically significant (at the a=0.05 level of significance) for
either the scale parameter (p=0.06) or the shape parameter
(p=0.49). The linear term for round was also not statistically
significant for either the scale parameter (p=0.08) or the shape
parameter (p=0.38). These results suggest that neither of the
parameter values differ from round 1 to round 2. Additionally,
when individual survival curves were fit to each of the eight sets of
data (assuming a Weibull distribution for survival times), none of
the scale or shape parameters within group were statistically
different (all p-values ,0.025). Therefore, round 1 and round 2
data were combined for the two strains constituting each F.
tularensis group (Figure 2c).
For comparisons between F. tularensis infection groups, differ-
ences were considered statistically significant if p,0.008, with this
level of significance determined using the Bonferroni adjustment
for multiple comparisons. Comparison between F. tularensis groups
indicated that the survival curve for A1b infected mice differed
significantly (p,0.008) in scale parameter as compared to survival
curves for A1a, A2 and type B infected mice. The shift of the curve
reflected that mice infected with A1b died earlier than mice
infected with A1a, A2 or type B (Figure 2c). The survival curves for
mice infected with A1a and A2 also differed significantly in scale
from the survival curve for mice infected with type B (p,0.008)
(Figure 2a and 2c). Additionally, the survival curve for mice
infected with A1a differed significantly (p,0.008) in shape from
the survival curves for mice infected with A1b, A2 and type B,
reflecting that mice died within a narrower timeframe when
infected with an A1a strain as compared to mice infected with
A1b, A2 or type B (Figure 2a). The survival curve for mice infected
with A1a did not differ significantly in scale from the survival curve
for mice infected with A2 (0.05,p,0.10).
Bacterial burdens in mice infected with F. tularensis A1a,
A1b, A2 and type B strains
To determine if differences in bacterial loads occurred among
mice infected with F. tularensis groups (A1a, A1b, A2, and type B),
bacterial burdens were determined at time of death and compared
among groups for blood, spleen, liver and lungs (Figure 3).
Comparisons were performed using an overall Type I error rate of
a=0.05, thus statistically significant results have an adjusted p
value ,0.05. Mean bacterial load in the blood and liver did not
differ significantly between rounds for any two strains of the same
F. tularensis group. Mean bacterial load in the spleen was higher in
round 2 (p,0.01). The increase in bacterial burden within the
spleen was consistent for all groups and the ordering of groups by
bacterial load was preserved from round 1 to round 2. The
interaction term between group and round was statistically
significant (p,0.01) for bacterial burdens in the lungs. This
suggests that the magnitude of differences in bacterial burdens for
lungs among the groups is not the same from round 1 to round 2.
As shown in Figure 3, our results indicated that the mean
bacterial load in both blood and spleen was statistically highest in
Figure 1. PFGE analysis of F. tularensis strains. A diagram depicting the eight F. tularensis strains used to infect mice (two strains per each of the
four F. tularensis groups, A1a, A1b, A2 and type B). F. tularensis subsp. tularensis strain Schu S4 (A1a) and LVS (type B) were included in the dendogram
as reference strains.
doi:10.1371/journal.pone.0010205.g001
F. tularensis Clade Virulence
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blood and spleen was in A2 infected mice, which was statistically
higher than that of either A1a or A1b infected mice. No statistical
difference in mean bacterial load was detected between A1a
infected mice and A1b infected mice in either blood or spleen
tissue. The estimated mean Log10 CFU/ml blood was 8.73, 9.08,
8.99, 9.01, 9.38, 9.27, 10.03 and 10.09 for A1a-1, A1a-2, A1b-1,
A1b-2, A2-1, A2-2, B-1 and B-2 infected mice, respectively. The
estimated mean Log10 CFU/spleen was 9.87, 10.02, 9.91, 10.16,
10.08, 10.25, 10.74 and 10.75 for A1a-1, A1a-2, A1b-1, A1b-2,
A2-1, A2-2, B-1 and B-2 infected mice, respectively.
In the liver, mean bacterial burden was also statistically highest
in type B infected mice (estimated mean Log10 CFU/liver of 11.27
for both B-1 and B-2). Mean bacterial burden in A2 infected mice
(Log10 CFU/liver of 10.78 and 10.86 for A2-1 and A2-2,
respectively) was statistically higher than in A1b infected mice
(Log10 CFU/liver of10.34 and 10.70 for A1b-1 and A1b-2,
respectively) but not higher than A1a infected mice (Log10 CFU/
liver of 10.55 and 10.83, for A1a-1 and A1a-2, respectively). There
was no statistical difference in mean bacterial burden in the liver
between A1a and A1b infected mice.
Mean bacterial loads in the lungs were statistically higher in
A2 (estimated mean Log10 CFU/liver of 9.95 and 9.32 for A2-1
and A2-2, respectively) and type B (estimated mean Log10
CFU/liver of 9.38 and 9.47 for B-1 and B-2, respectively)
infected mice as compared to A1a (estimated mean Log10 CFU/
liver of 8.82 and 8.97 for A1a-1 and A1a-2, respectively) and
A1b (estimated mean Log10 CFU/liver of 8.80 and 8.85 for
A1b-1 and A1b-2, respectively) infected mice. In round 1, mean
bacterial load was statistically higher in A2 infected mice than in
type B infected mice. No statistically significant differences in
lung bacterial burden were detected between A2 and type B
infected mice in round 2 or between A1a and A1b infected mice
in either round.
Figure 2. Survival curves of naı ¨ve mice following challenge with F. tularensis A1a, A1b, A2 and type B. C57BL/6J mice (n=14/group;
n=7/strain) were challenged intradermally with 10–20 CFU of F. tularensis A1a (strains OK01-2528 and MO02-4195), A1b (strains MD00-2970 and
MA00-2987), A2 (strains WY96-3418 and NM99-1823) and type B (strains KY99-3387 and MI00-1730), and survival was monitored over time. A) Time of
death for n=14 mice per F. tularensis group (A1a, A1b, A2 and type B). Circles represent mice infected in round 1(n=7) and triangles represent mice
infected in round 2 (n=7). B) Step-down survival curves for proportion of mice surviving over time (hours). Data shown is from round 1 and round 2
for A1a, A1b, A2 and type B data. Median times of death are noted as a bold cross. C) Fitted survival curves for proportion of mice surviving over time
(hours) using a Weibull distribution for combined (n=14 mice/group) round 1 and round 2 A1a, A1b, A2 and type B data.
doi:10.1371/journal.pone.0010205.g002
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A1b, A2, and type B strains
To determine if differences in gross anatomy occurred among
mice infected with F. tularensis A1a, A1b, A2, and type B strains,
the weight of each mouse and its spleen, liver and lungs were
measured at time of death (Figure 4). Multiple comparisons were
done with an overall Type I error rate of a=0.05, thus statistically
significant results have an adjusted p value ,0.05. No significant
differences were found in mouse weight between any of the
infection groups (p=0.07) or rounds (p=0.06). However, weight
loss was statistically lower in the control group compared to the
infection groups. Mice infected with all F. tularensis strains had an
overall average weight loss of 2.6 to 3.6 g as compared to non-
infected mice, with A2 and type B infected mice losing the least
amount of weight (Figure 4).
Mean spleen weight was found to be statistically higher in type
B infected mice than in any of the type A infected mice, while
mean spleen weight was statistically lowest in the control group.
Mean liver weight was statistically higher in type B infected mice
than in A1a infected mice in round 1 and was statistically higher in
type B infected mice than A1b infected mice in round 2. No other
statistical differences in mean liver weight by group or round were
detected. There was an inconsistent pattern in mean lung weight
between rounds 1 and 2. In round 1, A1a infected mice had a
statistically lower mean lung weight than A1b and type B infected
mice. Additionally, A2 infected mice had a statistically lower mean
lung weight than type B infected mice. In round 2, A1b infected
mice had a statistically lower mean lung weight than either A2 or
type B infected mice. The control group had a statistically lower
mean lung weight than A1b infected mice and type B infected
mice in round 2.
Gross changes in the liver and spleen were also identified at time
of death. Spleens and livers were noticeably enlarged in type B
infected mice as compared to non-infected mice or mice infected
with A1a, A1b or A2 strains and showed less discoloration than
those from mice infected with A1a, A1b or A2 strains (data not
shown). Additionally, tissue damage, both necrosis and granulo-
mas, were apparent in spleens of mice with A1a, A1b or A2 as
opposed to type B infected mice (data not shown).
Discussion
In this study, we demonstrate that geneticdifferences(cladesA1a,
A1b and A2) among F. tularensis subsp. tularensis strains, as identified
by PFGE and SNP typing, correlate directly with differences in
virulence as assessed using C57BL/6 mice. Among type A clades,
A1b strains were shown to be the most virulent in mice, with A1b
infected mice succumbing to infection at significantly earlier times
as compared to A1a and A2 infected mice. Additionally, A1a
infected mice died within a narrower time span than A1b or A2
infected mice, suggesting that A1a strains are either more clonal
Figure 3. Bacterial burden of F. tularensis within the blood, spleen, liver and lungs of infected mice. C57BL/6J mice (n=14/group) were
challenged intradermally with 10-20 CFU of F. tularensis A1a, A1b, A2, and type B. At time of death, organs were harvested and blood was taken from
each mouse. A) Bacterial burden (Log10 CFU/ml) within blood samples of all infection groups. No statistical difference was observed between round 1
and round 2. B) Bacterial burden (Log10 CFU/spleen) within spleens of all infection groups. A statistical difference was observed between round 1 and
round 2. C) Bacterial burden (Log10 CFU/liver) within livers of all infection groups. No statistical difference was observed between round 1 and round
2. D) Bacterial burden (Log10 CFU/lung) within lungs of all infection groups. A statistical difference was observed between round 1 and round 2. For
all graphs, significant differences (p,0.05) in Log10 CFU within round 1 infections and within round 2 infections are shown by different letters (A, B,
etc.). If two strains have the same letter, no significant differences were identified between them.
doi:10.1371/journal.pone.0010205.g003
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Importantly, virulence differences appeared to be conserved among
clades, as two representative strains with slightly differing PFGE
patterns from each type A clade, A1b, A1a and A2, were utilized in
this study. Virulencedifferences were also demonstrated between all
type A clades and type B.
Measurement of bacterial burden within the blood, spleen and
liver at the time of death in mice infected with A1a, A1b, A2 and
type B strains indicated a significantly higher bacterial load in type
B-infected mice as compared to mice infected with any of the type
A clades. Similarly, mice infected with A2 strains had significantly
higher bacterial loads in the blood and liver as compared to A1a
and A1b infected mice. A correlation between bacterial burden
and time to death was observed, with mice succumbing to
infection earlier (i.e. A1a and A1b infected mice) having lower
bacterial burdens than mice dying at later time points (i.e. A2 and
type B infected mice). This data demonstrates that higher bacterial
loads are needed for type B and A2 infected mice to die from
infection, as compared to A1a or A1b infected mice. It is unknown
if differences in growth rates exist between type A clades (A1a, A1b
and A2) or between type A clades and type B. In addition to type B
infected mice having higher bacterial burdens, organs were larger
in type B infected mice, indicative of a strong inflammatory
response that is not as pronounced in type A infected mice.
Our findings are in agreement with a study performed by Twine
et al., which demonstrated virulence differences between two type
A strains, Schu S4 and FSC033, in BALB/c mice [17]. Although
significant differences in survival curves were found between these
two strains, with FSC033 appearing more virulent than Schu S4,
they were not attributed to genetic differences. PFGE typing
demonstrates that Schu S4 is an A1a strain (Figure 1), whereas
analysis of the genome sequence for FSC033 shows it contains
single nucleotide polymorphisms characteristic of A1b strains (C at
position 93857 in the FSC033 genome using primer set 1574929
and a G at position 5357 in the FSC033 genome using primer set
518892) [13].
Due to the low infectious dose of F. tularensis for both type A and
type B in mice (LD50 ,10 CFU for both subspecies) and the acute
and rapid onset of infection that results, few studies have used a
mouse model to demonstrate tangible virulence differences
between F. tularensis strains [1,4,14,15]. Nonetheless, our results
indicate that survival curves can be used to assay differences in
virulence in mice among both type A clades and subspecies of F.
tularensis. Several factors are likely to be critical for identifying
virulence differences among F. tularensis strains using a mouse
model. In this study, we used death as an endpoint to generate
survival curves, thereby eliminating any bias in using signs of
morbidity to euthanize mice and determine time of death.
Towards this end we have defined a specific temperature during
infection that is an ethical indicator of death (unpublished
observation). In the future, the use of temperature as an
experimental endpoint will minimize pain and suffering of infected
Figure 4. Weight loss and spleen, liver and lung weights for mice infected with F. tularensis A1a, A1b, A2, and type B. C57BL/6J mice
(n=14/group) were challenged intradermally with 10-20 CFU of F. tularensis A1a, A1b, A2, and type B. Mice were weighed prior to infection and at
time of death. Organs were harvested and weighed at time of death. A) Mouse weight (grams) for each infection group and both control groups. No
statistical difference was observed between round 1 and round 2. B) Spleen weight (grams) for each infection group and both control groups. No
statistical difference was observed between round 1 and round 2. C) Liver weight (grams) for each infection group and both control groups. No
statistical difference was observed between round 1 and round 2. D) Lung weight (grams) for each infection group and both control groups. A
statistical difference was observed between round 1 and round 2. For all graphs, significant differences (p,0.05) in Log10 CFU within round 1
infections and within round 2 infections are shown by different letters (A, B, etc.). If two strains have the same letter, no significant differences were
identified between them.
doi:10.1371/journal.pone.0010205.g004
F. tularensis Clade Virulence
PLoS ONE | www.plosone.org 6 April 2010 | Volume 5 | Issue 4 | e10205animals and will also serve as a valuable tool for unbiased
comparisons of F. tularensis virulence. Monitoring mice every
2 hours over the time course of infection, rather than 24 hr
periods, was also important in this study for ensuring accuracy.
Finally, genotyped clinical strains were chosen for this study in
order to yield information directly related to previous epidemio-
logic findings [12].
The mechanisms underlying virulence differences among type A
clades and between type A clades and type B are not known. To
date, numerous studies have compared genetic variations present
between type A and type B strains at both the genome and protein
level and a few studies have also compared differences between
type A clades, A1 and A2 [10,20–24]. A previous study showed
that FSC033 was better able to disseminate as compared to Schu
S4 from the original inoculation site to the liver and spleen of
infected mice [17]. Consistent with A1b strains being better able to
disseminate is the epidemiologic finding that the majority of
isolates (67%) from patients infected with A1b strains were
recovered from invasive sites (blood, lung, pleural fluid or CSF) as
compared to patients infected with A1a (44%), A2 (10%) or type B
(37%) strains [12]. Rates of dissemination, immunological
responses, and tissue tropism are areas for future analyses.
In conclusion, our results correlate with epidemiological data for
human culture-confirmed tularemia cases in the United States,
which demonstrated that A1b infections were associated with
higher mortality as compared to A1a, A2 and type B infections
[12]. Here we showed that mice infected with A1b strains had a
significantly shortened survival time as compared to mice infected
with A1a, A2 or type B strains, demonstrating the importance of
human epidemiological data and how it can yield hypotheses that
can be studied in the laboratory. This finding will be important for
raising awareness in states where human infections with A1b
strains occur, which may aid in preventing mortality. The
virulence differences identified among type A clades indicate we
can no longer consider F. tularensis subsp. tularensis to be
biologically homogeneous and the need to shift our attention
from the subspecies to the clade level. Previous studies also showed
differences in geographic distributions among type A clades [8,20].
The demonstration of genetic and geographic, as well as virulence,
differences among the A1a, A1b and A2 clades brings into
question their classification, given that F. tularensis subsp. tularensis
was originally classified as a subspecies based on biochemical,
geographic and virulence differences [3].
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